Oncology
Metastatic Biliary Tract Carcinoma
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Metastatic Biliary Tract Carcinoma is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
1
clinical trials
Not yet recruiting1 · 100%
Clinical Trials
Trial Activity
Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma
Not yet recruiting·—·Phase 2·NCT06430827·20 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)